| Nazwa produktu: |
Grajanotoksyna III Hemi(octan etylu)*addukt |
| Synonimy |
Grajanotoksyna III;Andromedol; BRN 2059374; Deacetyloandromedotoksyna; Deacylazabotoksyna I;Grajanotoksan-3,5,6,10,14,16-heksol, (3-beta,6-beta,14R)-; 323778 NSC; (3beta,6beta,14R)-grajanotoksan-3,5,6,10,14,16-heksol; 7,9a-metano-9aH-cyklopenta(b)heptano-2,4,8,11,11a,12(1H)-heksol, dodekahydro-1,1,4,8-tetrametylo-, (2S,3as,4R,4ar,7R,8R,9as,11R,11aR,12R)-; Grajanotoksan-3,5,6,10,14,16-heksol, (3beta,6beta,14R)-(9CI); grajanotoksan-3,5,6,10,14,16-heksol; (1beta,3alfa,5alfa,6alfa,8beta,9alfa,10alfa,13beta,14S)-grajanotoksan-3,5,6,10,14,16-heksol; (3beta,6beta)-grajanotoksan-3,5,6,10,14,16-heksol |
| Angielska nazwa |
grayanotoxin iii hemi(ethyl acetate)*adduct;Grayanotoxin III; Andromedol; BRN 2059374; Deacetylandromedotoxin; Deacylasebotoxin I; Grayanotoxane-3,5,6,10,14,16-hexol, (3-beta,6-beta,14R)-; NSC 323778; (3beta,6beta,14R)-Grayanotoxane-3,5,6,10,14,16-hexol; 7,9a-Methano-9aH-cyclopenta(b)heptalene-2,4,8,11,11a,12(1H)-hexol, dodecahydro-1,1,4,8-tetramethyl-, (2S,3as,4R,4ar,7R,8R,9as,11R,11aR,12R)-; Grayanotoxane-3,5,6,10,14,16-hexol, (3beta,6beta,14R)- (9CI); grayanotoxane-3,5,6,10,14,16-hexol; (1beta,3alpha,5alpha,6alpha,8beta,9alpha,10alpha,13beta,14S)-grayanotoxane-3,5,6,10,14,16-hexol; (3beta,6beta)-grayanotoxane-3,5,6,10,14,16-hexol |
| MF |
C20H34O6 |
| Masie cząsteczkowej |
370.4804 |
| InChI |
InChI=1/C20H34O6/c1-16(2)13(21)7-12-18(4,25)11-6-5-10-15(23)19(11,9-17(10,3)24)8-14(22)20(12,16)26/h10-15,21-26H,5-9H2,1-4H3/t10?,11-,12-,13-,14+,15?,17+,18+,19-,20-/m0/s1 |
| Nr CAS |
4678-45-9 |
| Struktury molekularnej |
|
| Gęstość |
1.36g/cm3 |
| Temperatura wrzenia |
552.6°C at 760 mmHg |
| Współczynnik załamania |
1.619 |
| Temperatura zapłonu |
250.9°C |
| Ciśnienie pary |
1.63E-14mmHg at 25°C |
| Symbole zagrożenia |
|
| Kody ryzyka |
|
| Bezpieczeństwo opis |
|
|
PL
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PT
RU
SA
TR
